About Ferric Carboxymaltose API
Therapeutic CategoryNephrology
CAS Number
9007-72-1
API Technology
Iron Product
Dose Form
Injectable
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, China DMF, Malaysia DMF, Saudi Arabia
Mechanism of Action
Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron.
Indication
Injectafer is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients:
- Who have intolerance to oral iron or have had unsatisfactory response to oral iron;
- Who have non-dialysis dependent chronic kidney disease.
Related APIs
蔗糖铁
Nephrology
罗沙司他一水合物（晶型A）
Nephrology
伏环孢素
Nephrology
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related Resources
FAQs
Treats iron deficiency anemia in patients intolerant to oral iron or with chronic kidney disease
-
Monitor for allergic reactions
Avoid in patients with severe renal impairment
-
Store at 20°C to 25°C (68°F to 77°F), in a tightly closed container, protect from moisture
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。